Tarlatumab (Dosage and Administration)
The specific dosage and administration method will depend on several factors, including:
Type of cancer: The dosage may vary depending on the specific type of cancer being treated.
Stage of cancer: The stage of the cancer can also influence the dosage.
Overall health of the patient: The patient’s general health and other medical conditions will be considered when determining the appropriate dosage.
Dosage:
Typical dosage: The typical dosage of Tarlatumab is administered intravenously (IV) once every 21 days.
Dose adjustment: The dosage may be adjusted based on individual factors, such as adverse effects or response to treatment.
Administration:
IV infusion: Tarlatumab is typically administered as an IV infusion over a period of 30-60 minutes.
Healthcare professional: The infusion should be administered by a qualified healthcare professional in a medical setting.